Sequence Bio

company

About

Discovering the true signals of disease to power life-changing medicines.

  • 51 - 100

Details

Last Funding Type
Pre-seed
Industries
Biotechnology,Genetics,Therapeutics
Founded date
Jan 1, 2013
Number Of Employee
51 - 100
Operating Status
Active

90% of drug candidates fail, delaying help for those in need. We’re on a mission to change that. Better drug target discovery powered by the Newfoundland founder effect.

Funding Rounds

Number of Funding Rounds
Total Funding Amount
2
Sequence Bio has raised a total of — in funding over 2 rounds. Their latest funding was raised on Aug 3, 2016 from a Seed round.
Announced Date Round Money Raised Number of Investors Lead Investors Post Valuation
Aug 3, 2016 Seed 1 Detail
Oct 19, 2015 Pre-seed 1 Detail

Investors

Number of Lead Investors
Number of Investors
1
Sequence Bio is funded by 1 investors. Killick Capital are the most recent investors.
Investor Name Lead Investor Funding Round
Killick Capital Seed